These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 32387442)

  • 21. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
    Allam A; Yakou M; Pang L; Ernst M; Huynh J
    Front Immunol; 2021; 12():767939. PubMed ID: 34858425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
    Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
    Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression.
    Jena BC; Das CK; Bharadwaj D; Mandal M
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188416. PubMed ID: 32822826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.
    Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
    Front Immunol; 2023; 14():1152312. PubMed ID: 37033960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts.
    Andreucci E; Fioretto BS; Rosa I; Matucci-Cerinic M; Biagioni A; Romano E; Calorini L; Manetti M
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumoral microvesicle-activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma.
    Jiang E; Xu Z; Wang M; Yan T; Huang C; Zhou X; Liu Q; Wang L; Chen Y; Wang H; Liu K; Shao Z; Shang Z
    FASEB J; 2019 Apr; 33(4):5690-5703. PubMed ID: 30698991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities.
    Khan MA; Zubair H; Anand S; Srivastava SK; Singh S; Singh AP
    Cancer Lett; 2020 Mar; 473():176-185. PubMed ID: 31923436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblasts in the Tumor Microenvironment: Shield or Spear?
    Alkasalias T; Moyano-Galceran L; Arsenian-Henriksson M; Lehti K
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29883428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drilling for Oil: Tumor-Surrounding Adipocytes Fueling Cancer.
    Attané C; Muller C
    Trends Cancer; 2020 Jul; 6(7):593-604. PubMed ID: 32610069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in the Tumor Microenvironment.
    Patil N; Allgayer H; Leupold JH
    Adv Exp Med Biol; 2020; 1277():1-31. PubMed ID: 33119862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy.
    Liao Z; Tan ZW; Zhu P; Tan NS
    Cell Immunol; 2019 Sep; 343():103729. PubMed ID: 29397066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic heterogeneity in cancer: An overview and therapeutic implications.
    Tong Y; Gao WQ; Liu Y
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188421. PubMed ID: 32835766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism.
    Lee-Rueckert M; Canyelles M; Tondo M; Rotllan N; Kovanen PT; Llorente-Cortes V; Escolà-Gil JC
    Semin Cancer Biol; 2023 Aug; 93():36-51. PubMed ID: 37156344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblasts in the Tumor Microenvironment.
    Truffi M; Sorrentino L; Corsi F
    Adv Exp Med Biol; 2020; 1234():15-29. PubMed ID: 32040852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.
    Xiong Y; McDonald LT; Russell DL; Kelly RR; Wilson KR; Mehrotra M; Soloff AC; LaRue AC
    World J Stem Cells; 2015 Mar; 7(2):253-65. PubMed ID: 25815113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DT-13 inhibits breast cancer cell migration via non-muscle myosin II-A regulation in tumor microenvironment synchronized adaptations.
    Gao Y; Khan GJ; Wei X; Zhai KF; Sun L; Yuan S
    Clin Transl Oncol; 2020 Sep; 22(9):1591-1602. PubMed ID: 32056128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation in the tumor microenvironment.
    Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
    J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment.
    Lee SC; Lin KH; Balogh A; Norman DD; Bavaria M; Kuo B; Yue J; Balázs L; Benyó Z; Tigyi G
    Cell Signal; 2021 Feb; 78():109850. PubMed ID: 33253914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.